ViennaLab Diagnostics has released their first real-time PCR assay
for monitoring lung cancer patients
eligible for the alternative treatment with osimertinib (Tagrisso) due to acquired resistance to EGFR-tyrosine kinase inhibitor (TKI) therapy: EGFR T790M RealFast Assay.
For proper sample preparation, ViennaLab is offering a column-based Plasma cfDNA Extraction Kit
allowing isolation of high-purity circulating cell-free DNA
from fresh or frozen human plasma.
Exhibitor Data Sheet